Condition
Isolated Impaired Fasting Glucose
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Not Yet Recruiting1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06143345Not ApplicableWithdrawnPrimary
HIIT in Isolated IFG: A Proof-of-Concept Study
NCT06451055Not ApplicableNot Yet RecruitingPrimary
Low-calorie Diet in Isolated Impaired Fasting Glucose
NCT00140647Phase 3Completed
The Study of Atherosclerosis With Ramipril and Rosiglitazone
Showing all 3 trials